Clinical Summary: KCNx Database
The KCNx Database is a tool specialized in the KCNx family of potassium channels, essential for the diagnosis and management of congenital neurological disorders in childhood.
Objective and Clinical Application
- Facilitates the differential diagnosis of early epilepsies, ataxias and developmental disorders.
- Enables functional interpretation of genetic variants in K⁺ channels using tissue expression data and impact prediction.
- Integrates prediction algorithms (CADD, REVEL, PolyPhen-2) to evaluate pathogenicity.
Main Associated Syndromes
- KCN1 (Kv1.1): Episodic ataxia and paralysis syndrome type 1 (EA1). Phenotype: intermittent ataxia, tremors, partial seizures. Mutations in S6 domain → reduction of K⁺ current.
- KCN2 (Kv2.1): Neonatal epilepsy with severe hypotonia, progressive encephalopathy and cardiac anomalies (associated Brugada syndrome).
- KCN13 (Kv13): Associated with dysfunction in intracellular potassium homeostasis during brain development.

The integration of fetal tissue expression data allows predicting the impact of a mutation on specific stages of brain development.
Clinical Use and Limitations
- Allows interactive therapeutic guidance: e.g. acetazolamide or lamotrigine to stabilize membrane in EA1.
- Limitations: does not include all described phenotypes; Functional predictions require experimental validation.
